- Home
- PARR vs ARQT Comparison
PARR vs ARQT Comparison
Compare PARR & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PARR
- ARQT
- Stock Information
- Founded
- PARR 1984
- ARQT 2016
- Country
- PARR United States
- ARQT United States
- Employees
- PARR N/A
- ARQT N/A
- Industry
- PARR Integrated oil Companies
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- PARR Energy
- ARQT Health Care
- Exchange
- PARR Nasdaq
- ARQT Nasdaq
- Market Cap
- PARR 971.9M
- ARQT 1.1B
- IPO Year
- PARR N/A
- ARQT 2020
- Fundamental
- Price
- PARR $15.62
- ARQT $13.02
- Analyst Decision
- PARR Buy
- ARQT Strong Buy
- Analyst Count
- PARR 7
- ARQT 6
- Target Price
- PARR $24.14
- ARQT $17.00
- AVG Volume (30 Days)
- PARR 1.0M
- ARQT 2.3M
- Earning Date
- PARR 02-25-2025
- ARQT 02-25-2025
- Dividend Yield
- PARR N/A
- ARQT N/A
- EPS Growth
- PARR N/A
- ARQT N/A
- EPS
- PARR 5.32
- ARQT N/A
- Revenue
- PARR $8,325,746,999.00
- ARQT $138,708,000.00
- Revenue This Year
- PARR N/A
- ARQT $217.37
- Revenue Next Year
- PARR N/A
- ARQT $55.64
- P/E Ratio
- PARR $2.94
- ARQT N/A
- Revenue Growth
- PARR 5.96
- ARQT 182.84
- 52 Week Low
- PARR $14.84
- ARQT $6.99
- 52 Week High
- PARR $40.70
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- PARR 41.52
- ARQT 50.16
- Support Level
- PARR $15.36
- ARQT $11.13
- Resistance Level
- PARR $16.57
- ARQT $13.62
- Average True Range (ATR)
- PARR 0.90
- ARQT 1.04
- MACD
- PARR -0.15
- ARQT 0.08
- Stochastic Oscillator
- PARR 10.31
- ARQT 67.26
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.